The NSE concentration below 2 ng/ml in the blood of patients in the acute period of ischemic stroke allows one to predict good functional outcome at 12–14 days after disease onset and along with the severity of neurological symptoms below the score of 15 (NIHSS) is a predictor of significant motor function recovery. The gene discussed is ENO2; the disease is ischemic stroke.